Inovio Pharmaceuticals (INO) Current Deferred Tax Assets (2012 - 2015)
Inovio Pharmaceuticals (INO) posted Current Deferred Tax Assets of $342573.0 for Q3 2015, little changed sequentially from $342573.0 in Q2 2015, and up 453.98% YoY from $61839.0 in Q3 2014.
Inovio Pharmaceuticals (INO) Current Deferred Tax Assets (2012 - 2015) Analysis & Trends
Inovio Pharmaceuticals has reported Current Deferred Tax Assets for 4 years, with the latest figure at $342573.0 in Q3 2015.
- Quarterly Current Deferred Tax Assets rose 453.98% year-over-year to $342573.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $342573.0 (up 453.98% YoY) and the FY2014 annual result came in at $342573.0, up 453.98% from the prior year.
- Current Deferred Tax Assets was little changed at $342573.0 in Q3 2015 per INO's latest filing, from $342573.0 in the prior quarter.
- Over five years, Current Deferred Tax Assets peaked at $342573.0 in Q4 2014 and troughed at $61839.0 in Q4 2013.
- A 4-year average of $155713.3 and a median of $62728.0 in 2012 frame the typical range for Current Deferred Tax Assets.
- The sharpest annual moves came in 2013 and 2014: Current Deferred Tax Assets decreased 1.42% in 2013, then jumped 453.98% in 2014.
- Over 4 years, Current Deferred Tax Assets stood at $62728.0 in 2012, then decreased by 1.42% to $61839.0 in 2013, then surged by 453.98% to $342573.0 in 2014, then changed by 0.0% to $342573.0 in 2015.
- According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $342573.0, $342573.0, and $342573.0 for Q3 2015, Q2 2015, and Q1 2015 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Inovio Pharmaceuticals | 96.32 Mn | 96.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 342,573.00 |
| Sep 30, 2015 | 342,573.00 |
| Jun 30, 2015 | 342,573.00 |
| Jun 30, 2015 | 342,573.00 |
| Mar 31, 2015 | 342,573.00 |
| Mar 31, 2015 | 342,573.00 |
| Dec 31, 2014 | 342,573.00 |
| Dec 31, 2014 | 342,573.00 |
| Sep 30, 2014 | 61,839.00 |
| Sep 30, 2014 | 61,839.00 |
| Jun 30, 2014 | 61,839.00 |
| Jun 30, 2014 | 61,839.00 |
| Mar 31, 2014 | 61,839.00 |
| Mar 31, 2014 | 61,839.00 |
| Dec 31, 2013 | 61,839.00 |
| Dec 31, 2013 | 61,839.00 |
| Sep 30, 2013 | 62,728.00 |
| Sep 30, 2013 | 62,728.00 |
| Jun 30, 2013 | 62,728.00 |
| Jun 30, 2013 | 62,728.00 |